Queen Mary Hospital
Hong Kong
NCT Number: NCT00839592
This is a randomized controlled trial to evaluate acupuncture treatment on insomnia in the adult population in Hong Kong.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Hong Kong
Acupuncture is potential to be an alternative treatment for primary insomnia. The purpose of this study is to evaluate the clinical effectiveness of acupuncture treatment on primary insomnia. This is a randomized single-blinded controlled trial. Patients will be randomly assigned to the electro-acupuncture group or the placebo acupuncture group. Patients will be put into groups and then compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Acupuncture at bilateral Ear Shenmen, Sishencong EX-HN1, Anmian, and unilateral Yintang EX-HN3 and Baihui GV20. The needles will be left for 30 min and then removed. Acupuncture treatment will consist of three sessions per week for 3 consecutive weeks.
Other names: Acupuncture
Time frame: Baseline, weekly during the treatment course, 1-week posttreatment
Time frame: Baseline, and 1-week posttreatment
Time frame: Baseline, weekly during the treatment course, and 1-week posttreatment
Time frame: Baseline, and 1-week posttreatment
Time frame: Baseline, and 1-week posttreatment
Time frame: Baseline, and 1-week posttreatment
Time frame: Second and the last time of the treatment
The University of Hong Kong
Other
Acupuncture Treatment of Primary Insomnia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03665337
Delayed Sleep Phase, Dyssomnias
San Francisco, California, United States
View Trial DetailsNCT07417163
Cirrhosis, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT04936321
Brain Diseases, Central Nervous System Diseases
Seattle, Washington, United States
View Trial DetailsNCT03018912
Apnea, Chronobiology Disorders
Fontana, California, United States
View Trial Details